M K Proteins Ltd Annual Results: Standalone & Consolidated Reports

Annual Results

Results Snapshot

Figures in Cr

Standalone Annual Results

Mar'26

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

Annual Analysis Highlights

Net Sales

YoY Growth in year ended Mar 2026 is 43.02% vs 9.02% in Mar 2025

Standalone Net Profit

YoY Growth in year ended Mar 2026 is -18.69% vs -25.07% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -8.05% vs -25.21% in Mar 2025

Interest

YoY Growth in year ended Mar 2026 is 66.67% vs 4.72% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Compare Annual Results Of M K Proteins With

Select Peers

Figures in Cr

Standalone Annual Results

Change(INR)

Change(%)

Net Sales

382.88

1,307.67

-924.79

-70.72%

Other Operating Income

0.00

Total Operating income

382.88

1,307.67

-924.79

-70.72%

Raw Material Cost

286.49

1,103.40

-816.91

-74.04%

Purchase of Finished goods

73.69

133.14

-59.45

-44.65%

(Increase) / Decrease In Stocks

-7.17

0.68

-7.85

-1,154.41%

Employee Cost

3.03

9.81

-6.78

-69.11%

Power Cost

0.00

21.30

-21.30

-100.00%

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

8.07

-8.07

-100.00%

Other Expenses

15.41

19.07

-3.66

-19.19%

Total Expenditure (Excl Depreciation)

371.45

1,295.47

-924.02

-71.33%

Operating Profit (PBDIT) excl Other Income

11.43

12.20

-0.77

-6.31%

Other Income

0.26

6.97

-6.71

-96.27%

Operating Profit (PBDIT)

11.69

19.17

-7.48

-39.02%

Interest

1.85

3.99

-2.14

-53.63%

Exceptional Items

0.00

Gross Profit (PBDT)

9.84

15.18

-5.34

-35.18%

Depreciation

0.44

3.11

-2.67

-85.85%

Profit Before Tax

9.39

12.07

-2.68

-22.20%

Tax

2.56

3.69

-1.13

-30.62%

Provisions and contingencies

0.00

Profit After Tax

6.83

8.38

-1.55

-18.50%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

6.83

8.38

-1.55

-18.50%

Equity Capital

37.54

16.10

21.44

133.17%

Face Value

1.00

2.00

0.00

Reserves

38.76

0.00

38.76

Earnings per share (EPS)

0.18

1.04

-0.86

-82.69%

Diluted Earnings per share

0.18

1.04

-0.86

-82.69%

Operating Profit Margin (Excl OI)

2.99%

0.93%

0.00

2.06%

Gross Profit Margin

2.57%

1.16%

0.00

1.41%

PAT Margin

1.78%

0.64%

0.00

1.14%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Annual - Net Sales

Net Sales 382.88 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is 43.02% vs 9.02% in Mar 2025

Annual - Standalone Net Profit

Standalone Net Profit 6.83 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is -18.69% vs -25.07% in Mar 2025

Annual - Operating Profit (PBDIT)

Operating Profit (PBDIT) 11.43 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is -8.05% vs -25.21% in Mar 2025

Annual - Interest

Interest 1.85 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is 66.67% vs 4.72% in Mar 2025

Annual - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 2.99%

in Mar 2026

Figures in %

YoY Growth in year ended Mar 2026 has fallen from Mar 2025